FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Eluden 4.6mg/24hours transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 10micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 15micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 300micrograms/24hours transdermal patches (J M McGill Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 15micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (HFA Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour patches (A A H Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (Actavis UK Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 9.5mg/24hours transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Eluden 9.5mg/24hours transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 20micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 5micrograms/hour transdermal patches (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voltarol Gel Patch 1% medicated plasters (Novartis Consumer Health UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12 transdermal patches (Janssen-Cilag Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (PI) (Dowelhurst Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 1mg/24hours transdermal patches (UCB Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Necessity Supplies Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 37.5microgram/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mylafent 12micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Schwarz Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 1 patches (Boehringer Ingelheim Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 300micrograms/24hours transdermal patches (Special Order) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 3mg/24hours transdermal patches (UCB Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Lexon (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fencino 12micrograms/hour transdermal patches (Luye Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Intrinsa 300micrograms/24hours transdermal patches (Lexon (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (A A H Pharmaceuticals Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 4.6mg/24hours transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Somniton 9.5mg/24hours transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Boots NicAssist Translucent 25mg/16hours patches (The Boots Company Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 5micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 10micrograms/hour transdermal patches (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Sevodyne 20micrograms/hour transdermal patches (Aspire Pharma Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Mezolar Matrix 12micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 2 patches (Boehringer Ingelheim Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (Nycomed (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Novartis Pharmaceuticals UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Osmanil 12micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivatev 9.5mg/24hours transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Prometax 4.6mg/24hours transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testosterone 2.4mg/24hours transdermal patches (Special Order) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Yemex 12micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (DE Pharmaceuticals) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Victanyl 12micrograms/hour transdermal patches (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evra transdermal patches (Gedeon Richter (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (Accord Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Catapres TTS 3 patches (Boehringer Ingelheim Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Clonidine 200micrograms/24hours transdermal patches (Special Order) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (Mawdsley-Brooks & Company Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Doncaster Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 5micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Testopatch 2.4mg/24hours transdermal patches (Imported (Greece)) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Waymade Healthcare Plc) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Fentanyl 12micrograms/hour transdermal patches (Phoenix Healthcare Distribution Ltd) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 4.6mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 9.5mg/24hours transdermal patches (DE Pharmaceuticals) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Erastig 13.3mg/24hours transdermal patches (Teva UK Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 5micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Reletrans 10micrograms/hour transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 10micrograms/hour transdermal patches (Napp Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Nicorette invisi 25mg/16hours patches (McNeil Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Jointace deep aroma transdermal patches (Vitabiotics Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (Waymade Healthcare Plc) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (Necessity Supplies Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 4.6mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 9.5mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 9.5mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Rivastigmine 4.6mg/24hours transdermal patches (DE Pharmaceuticals) Has manufactured dose form False Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Voleze 13.3mg/24hours transdermal patches (Focus Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Panitaz 10micrograms/hour transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 15micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 15micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Butec 15micrograms/hour transdermal patches (Qdem Pharmaceuticals Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 70micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 52.5micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 35micrograms/hour transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 70micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 52.5micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Relevtec 35micrograms/hour transdermal patches (Sandoz Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 4.6mg/24hours transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 4.6mg/24hours transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 4.6mg/24hours transdermal patches (Sandoz Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 9.5mg/24hours transdermal patches (Sandoz Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 5micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 5micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 10micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 10micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Bupramyl 20micrograms/hour transdermal patches (Viatris UK Healthcare Ltd) Has manufactured dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Previous Page 19 of 21 Next End

This concept is not in any reference sets

Back to Start